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Zygotic Wnt signaling has been shown to be involved in dorsoventral mesodermal patterning in Xenopus embryos, but how
it regulates different myogenic gene expression in the lateral mesodermal domains is not clear. Here, we use transient
exposure of embryos or explants to lithium, which mimics Wnt/-catenin signaling, as a tool to regulate the activation of
this pathway at different times and places during early development. We show that activation of Wnt/-catenin signaling
at the early gastrula stage rapidly induces ectopic expression of XMyf5 in both the dorsal and ventral mesoderm. In situ
hybridization analysis reveals that the induction of ectopic XMyf5 expression in the dorsal mesoderm occurs within 45 min
and is not blocked by the protein synthesis inhibitor cycloheximide. By contrast, the induction of XMyoD is observed after
2 h of lithium treatment and the normal expression pattern of XMyoD is blocked by cycloheximide. Analysis by RT-PCR
of ectodermal explants isolated soon after midblastula transition indicates that lithium also specifically induces XMyf5
expression, which takes place 30 min following lithium treatment and is not blocked by cycloheximide, arguing strongly
for an immediate-early response. In the early gastrula, inhibition of Wnt/-catenin signaling blocks the expression of XMyf5
and XMyoD, but not of Xbra. We further show that zygotic Wnt/-catenin signaling interacts specifically with bFGF and
eFGF to promote XMyf5 expression in ectodermal cells. These results suggest that Wnt/-catenin pathway is required for
regulating myogenic gene expression in the presumptive mesoderm. In particular, it may directly activate the expression of
the XMyf5 gene in the muscle precursor cells. © 2002 Elsevier Science (USA)
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The skeletal body muscle of vertebrates is derived from the
paraxial mesoderm that is characterized by the formation of
somites. The steps leading to the formation of functional
muscle cells and the factors involved in the specification and
commitment of precursor cells have been the object of intense
studies. One of the major discoveries has been the identifica-
tion of the myogenic bHLH transcription factors capable of
converting nonmuscle cells to skeletal muscle cells in culture
(reviewed by Weintraub et al., 1991). Among these factors,
Myf5 and MyoD have early functions in the determination
process that commits multipotential mesodermal cells to the
myogenic lineage. Soon after their formation, the somites
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124become patterned in response to local signals from the sur-
rounding tissues. Signals from the neural tube, the floor
plate/notochord complex, the dorsal ectoderm, and the lateral
plate mesoderm act either positively or negatively on the
different myogenic precursor populations to regulate the ex-
pression of myogenic bHLH genes. Candidate molecules for
these signaling activities include Sonic Hedgehog, the Wnt
proteins, noggin, and BMP-4 (Mu¨nsterberg et al., 1995; re-
viewed by Buckingham, 1997; McGrew and Pourquie´, 1998;
Cossu and Borello, 1999).
The control of spatiotemporal expression of myogenic
genes during early stages of development is a key event in
the initial step of myogenesis; it acts to restrict the expres-
sion of these genes in the future muscle cells. Although the
myogenic bHLH proteins are essential for the establish-
ment of muscle cell precursors and their differentiation,
little is known about the signals that activate their expression
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at the right time and place and therefore specify mesodermal
precursor cells to the myogenic lineage. Members of the Wnt
family were shown to regulate myogenic gene expression both
in vivo and in vitro (reviewed by Tajbakhsh and Buckingham,
1999; Cossu and Borello, 1999). Wnts are a family of secreted
proteins involved in a wide range of developmental processes
(reviewed by Moon, 1993; Cadigan and Nusse, 1997; Wodarz
and Nusse, 1998). The canonical Wnt/-catenin signaling
pathway involves cytoplasmic components such as dishev-
elled, GSK-3, and -catenin, and is evolutionarily conserved.
In both cultured mouse paraxial mesoderm explants and chick
limb bud, Wnts differentially regulate the expression of myo-
genic bHLH genes. Wnt-1, which activates the canonical
Wnt/-catenin pathway, preferentially activates the expres-
sion of Myf5, whereas Wnt-7a, which activates a -catenin-
independent pathway (Kengaku et al., 1998), preferentially
activates the expression of MyoD (Tajbakhsh et al., 1998).
Differential regulation of Myf5 and MyoD expression has also
been observed in Wnt-1/Wnt-3A double mutant mice that
exhibit severely reduced expression of Myf5 at 9.5 days post-
coitum (Ikeya and Takada, 1998). These observations suggest
that the regulation of myogenic gene expression may involve
distinct Wnt pathways. Delta/Notch signaling also differen-
tially affects the expression of MyoD and Myf5. In chick
embryos, activated Notch signaling suppresses the expression
of MyoD but not Myf5 (Delfini et al., 2000; Hirsinger et al.,
2001). This is consistent with the genetic hierarchy that
places Myf5 upstream of MyoD (Tajbakhsh et al., 1997;
reviewed by Tajbakhsh and Buckingham, 2000).
In Xenopus, a low level of maternal transcripts for
XMyoDa is distributed uniformly in the embryo, and zy-
gotic transcription of XMyoDa and XMyoDb genes at the
time of midblastula transition (MBT) occurs weakly across
the whole embryo (Harvey, 1991; Frank and Harland, 1991;
Rupp and Weintraub, 1991). Mesoderm induction may then
play a role to amplify and stabilize XMyoD gene expression
only in the presumptive muscle cells (Hopwood et al., 1989,
1992; Harvey, 1990, 1991; Frank and Harland, 1991; Rupp
and Weintraub, 1991). In addition, the expression of XMyoD
may be an immediate response to mesoderm-inducing sig-
nals such as activin (Steinbach et al., 1998). Unlike XMyoD,
maternal transcripts have not been detected for XMyf5
(Hopwood et al., 1991; reviewed by Gurdon et al., 1992) and
its zygotic expression is only detected in the dorsolateral
mesoderm, where it overlaps with XMyoD (Hopwood et al.,
1991; Dosch et al., 1997). Whether XMyf5 is regulated by
mesoderm-inducing signals in a similar way as XMyoD is
not clear, but BMP-4 signaling may play a role in its
patterning in the dorsolateral mesoderm at the early gas-
trula stage (Dosch et al., 1997).
Inhibition of Wnt signaling through overexpression of a
dominant negative mutant of Xwnt-8 or frzb-1, a secreted
antagonist of Wnt, revealed that Wnt signaling may be re-
quired for the expression of MyoD and myogenesis (Hoppler et
al., 1996; Leyns et al., 1997; Wang et al., 1997; Borello et al.,
1999). Conversely, injection in the Xenopus embryo of CSKA-
Xwnt-8 DNA, which places Xwnt-8 cDNA under the control
of cytoskeletal actin promoter and allows the expression of
Xwnt-8 protein after MBT, results in ectopic XMyoD and
XMyf5 expression in the dorsal mesoderm (Christian and
Moon, 1993; Marom et al., 1999). This ectopic expression of
XMyf5 and XMyoD was thought to be a consequence of
zygotic Xwnt-8 to ventralize the fate of dorsal mesoderm
(Christian and Moon, 1993; Hoppler and Moon, 1998). Thus,
whether Wnt signaling directly regulates XMyf5 and XMyoD
expression is still not clear.
In the present study, we analyzed the regulation of XMyf5
and XMyoD by zygotic Wnt/-catenin signaling at the
initial step of myogenesis. We used misexpression of
Xwnt-8 after MBT and transient exposure of whole embryos
or tissue explants to lithium, which inhibits GSK-3 activ-
ity and mimics Wnt/-catenin signaling (Klein and Melton,
1996; Stambolic et al., 1996; Brannon and Kimelman, 1996).
Our results indicate that the expression of XMyf5, but not
of XMyoD, induced by activation of zygotic Wnt/-catenin
signaling is an immediate-early response. It occurs indepen-
dently of the repression or activation of other dorsoventral
mesodermal genes. In particular, this induction can take
place in the absence of protein synthesis and is observed
before the downregulation of different Spemann organizer
genes. These analyses suggest that a zygotic Wnt/-catenin
signaling pathway acts upstream of XMyf5 to activate a
myogenic program at the initial stage of myogenesis.
MATERIALS AND METHODS
Embryonic Manipulations
Xenopus eggs were obtained from females injected with 500 IU
of human chorionic gonadotropin (Sigma), and artificially fertilized
with minced testis. Eggs were dejellied with 2% cysteine hydro-
chloride (pH 7.8) and kept in 0.1 modified Barth solution (MBS)
for further manipulations. Whole embryos or animal cap explants
at different stages were incubated for 15 min in 0.3 M LiCl solution
made in 0.1MBS. They were then washed in 0.1MBS (for whole
embryos) or 1 MBS (for animal cap explants) and cultured for an
appropriate period before harvesting for in situ hybridization or
RT-PCR. For cycloheximide (CHX) treatment of whole embryos,
vitelline membrane was removed with forceps, and at the same
time, a hole in the animal pole was made to facilitate exposure of
inner cells to CHX. To analyze the effects of CHX on lithium-
induced gene expression, embryos or explants dissected at different
stages were first incubated in 10 g/ml CHX (Sigma) for 30 min
followed by exposure to 0.3 M LiCl in the presence of CHX. After
these treatments, they were maintained in 0.1 or 1 MBS in the
presence of CHX. The efficiency of CHX to inhibit protein synthe-
sis was assayed in ectodermal explants treated with activin. We
found that activin-induced expression of chordin that requires
protein synthesis (Sasai et al., 1994) was reduced to 70–80%
following a previous treatment with CHX, as quantified by a
PhosphorImager (not shown).
For mesoderm induction assay, animal cap explants from control
and injected embryos were dissected at stage 8–9 and treated with
50 ng/ml bFGF (R&D Systems) or 10 U/ml activin (provided by Dr.
J. Smith) in 1 MBS. They were cultured to stage 11 for RT-PCR
analysis of gene expression.
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Microinjections
A dominant negative Tcf-3 mutant with the N-terminal 87
amino acids of the -catenin-binding domain deleted (Molenaar
et al., 1996) was generated by PCR using the following primers:
5-ATAGAATTCACAGGATGCAGCGTTCTTC-3 and 5-AG-
TTCTAGATTCTCCATCATCAGTC-3 with an EcoRI and XbaI
site (underlined), respectively. The PCR product was cloned in
the pCS2-MT vector (Turner and Weintraub, 1994) in-frame with
the six myc epitopes. Xenopus eFGF, GSK-3, Xdd1, and Xwnt-8
constructs were described previously (Isaacs et al., 1992; Umb-
hauer et al., 2000). Synthetic capped mRNAs were made by in
vitro transcription as described (Umbhauer et al., 2000). Em-
bryos were injected at the four-cell stage in 0.1 MBS containing
3% Ficoll-400. CKSA-Xwnt-8 DNA was injected directly with-
out previous linearization of the plasmid. After mRNA or DNA
injections, embryos were kept in 3% Ficoll-400 solution for 3 h
and then cultured in 0.1 MBS until they reached appropriate
stages (Nieuwkoop and Faber, 1967).
In Situ Hybridization and RT-PCR
Whole-mount in situ hybridization was performed according
to standard protocol (Harland, 1991) by using BM purple (Boehr-
inger Mannheim) as a substrate. Comparison of gene expression
patterns was always performed by using the same batch of
embryos that were treated in the same condition. Probes for
chordin, Xbra, Xwnt-8, XMyf-5, and XMyoDa were described
previously (Dosch et al., 1997; Djiane et al., 2000), and the
Xenopus myosin light chain cDNA was provided by Dr. T.
Mohun. For RT-PCR, RNA samples were treated with RNase-
free DNase I (Boehringer Mannheim) and were reverse-
transcribed by using 200 units SuperScript (Life Technologies).
PCR was described previously (Umbhauer et al., 2000). PCR
primers for XMyf5 (Hopwood et al., 1991) are as follows:
5-CTATTCAGAATGGAGATGGT-3 and 5-GTCTTGGAGA-
CTCTCAATA-3. Primers for XMyoDa, Xbra, Xwnt-8, goose-
coid, chordin, and ornithine decarboxylase (ODC) were as
described (Rupp and Weintraub, 1991; Djiane et al., 2000).
RESULTS
Ectopic Induction of XMyf5 and XMyoD, but Not
of Other Mesodermal Genes, by CSKA-Xwnt-8
Injection and Lithium Treatment
in the Early Gastrula
Previous studies have separately analyzed the regulation
of XMyf5 and XMyoD by Wnt signaling in the context of
dorsoventral patterning of marginal mesoderm (Hoppler
and Moon, 1998; Marom et al., 1999). Thus, it is not clear
how zygotic Wnt signaling pathway regulates XMyf5 and
XMyoD expression at the time of midblastula transition
and which Wnt signaling pathway is involved. To address
these questions, we first injected CSKA-Xwnt-8 DNA (200
pg) into the dorsal and ventral equatorial region of four-cell
stage embryos and performed whole-mount in situ hybrid-
ization to analyze the expression of XMyf5 and XMyoD at
the early gastrula stage. In control embryo, the expression
of XMyf5 and XMyoD is localized to the lateral marginal
zone mesoderm; the expression of XMyoD also extends to
the ventral marginal zone. However, expression of both
genes is excluded in the dorsal region (Figs. 1A and 1B).
Dorsal injection of CSKA-Xwnt-8 resulted in strong ectopic
expression of XMyf5, causing a fusion of the two lateral
XMyf5 expression domains in the dorsal mesoderm (Fig.
1E). The ectopic domains of XMyf5 also include dorsal
ectoderm; this indicates that Xwnt-8 was able to induce
XMyf5 expression in different cell types. Dorsal injection of
CSKA-Xwnt-8 also induced ectopic XMyoD expression in
the dorsal mesoderm, but to a much lesser extent in the
dorsal ectoderm (Fig. 1F). Coinjection of -galactosidase
mRNA as a cell lineage tracer indicated that the localiza-
tion and expression of injected Xwnt-8 were similar be-
tween embryos hybridized with XMyf5 and XMyoD probes
(not shown). Thus, this result implies that XMyf5 is more
sensitive to zygotic Wnt signaling and extends previous
observations (Christian and Moon, 1993; Hoppler and
Moon, 1998; Marom et al., 1999). Further, ventral injection
FIG. 1. Ectopic expression of XMyf5 and XMyoD following CSKA-Xwnt-8 injection and lithium treatment. (A) XMyf5 expression in a
control early gastrula is localized to the two lateral mesoderm domains. (B) XMyoD expression in a control early gastrula is localized to the
two lateral mesoderm domains and in ventral mesoderm. (C) Chordin expression in the dorsal mesoderm of a control early gastrula. (D)
Xwnt-8 expression in the lateroventral mesoderm of a control early gastrula. (E, F) Dorsal injection of CSKA-Xwnt-8 induces ectopic XMyf5
(E) and XMyoD (F) expression in the dorsal mesoderm and ectoderm. (G, H) Ventral injection of CSKA-Xwnt-8 induces ectopic XMyf5
expression in the ventral mesoderm and ectoderm (G), and enhances XMyoD expression in the ventral mesoderm and weakly induces its
ectopic expression in the ectoderm (H). (I, J) Lithium treatment induces ectopic XMyf5 (I) and XMyoD (J) expression in the dorsal mesoderm.
(K, L) Lithium treatment does not modify the expression pattern of chordin (K) and Xwnt-8 (L).
FIG. 2. Inhibition of Wnt/-catenin signaling blocks XMyf5 and XMyoD expression in early gastrula. Embryos at the four-cell stage were
injected with GSK-3, Xdd1, or dnTcf3 mRNA into the lateral marginal zone. (A) An uninjected embryo showing normal XMyf5 expression
pattern. (B–D) Injection of GSK-3 (B), Xdd1 (C), or dnTcf3 (D) mRNA blocks XMyf5 expression. (E) An uninjected embryo showing normal
XMyoD expression pattern. (F–H) Injection of GSK-3 (F), Xdd1 (G), or dnTcf3 (H) mRNA blocks XMyoD expression. (I) Xbra expression
in an uninjected embryo. (J–L) Injection of GSK-3 (J), Xdd1 (K), or dnTcf3 (L) mRNA does not affect Xbra expression. (M) Myosin light chain
expression in a stage 28 control embryo. (N–P) Injection of GSK-3 (N), Xdd1 (O), or dnTcf3 (P) mRNA partially blocks the formation of
somitic mesoderm and results in shortened embryos.
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of CSKA-Xwnt-8 strongly induced ectopic XMyf5 expres-
sion in both the mesoderm and ectoderm (Fig. 1G). By
contrast, it moderately enhanced the ventral expression of
XMyoD and weakly induced ectopic XMyoD expression in
the ectoderm (Fig. 1H). These analyses indicate clearly that
zygotic Wnt signaling preferentially induces XMyf5 expres-
sion.
Since lithium inhibits GSK-3 activity and mimics the
canonical Wnt/-catenin signaling (Klein and Melton, 1996;
Stambolic et al., 1996), we next assayed transient exposure
of embryos to lithium as a convenient tool to analyze
whether zygotic activation of Wnt/-catenin pathway in-
duces XMyf5 and XMyoD expression. Embryos at stage 10
were exposed to 0.3 M lithium for 15 min; they were
allowed to develop to stage 10.5–11 for whole-mount in situ
hybridization. As in CSKA-Xwnt-8-injected embryos,
lithium treatment led to ectopic expression of XMyf5 (Fig.
1I) and XMyoD (Fig. 1J) in the dorsal mesoderm. Compared
with CSKA-Xwnt-8-injected embryos, the lack of hybrid-
ization signal in the ectoderm of lithium-treated embryos is
likely due to the uniform exposure of these embryos to
lithium. By contrast, injection of CSKA-Xwnt-8 DNA led to
a more localized activation of Wnt/-catenin signaling and
thus a localized accumulation of XMyf5 and XMyoD tran-
scripts. Indeed, RT-PCR analysis indicated that lithium
treatment of ectoderm induced the expression of XMyf5 and
XMyoD (see Figs. 3 and 4I). This result implies that a
zygotic Wnt signaling pathway that involves inhibition of
GSK-3 activity is involved in regulating XMyf5 and
XMyoD expression.
Dorsal injection of CSKA-Xwnt-8 DNA was shown to
ventralize the fate of dorsal mesoderm (Christian and
Moon, 1993; Moon et al., 1993; Hoppler and Moon, 1998).
To examine whether the ectopic expression of XMyf5 and
XMyoD in the dorsal region results from an indirect conse-
quence of ventralization of dorsal mesoderm, we analyzed
the expression pattern of several dorsoventral mesodermal
markers in lithium-treated early gastrula, as above. The
results indicate that the expression pattern of Spemann
organizer marker chordin (Figs. 1C and 1K) and of the
lateroventral mesodermal marker Xwnt-8 (Figs. 1D and 1L)
did not significantly vary between control and lithium-
treated embryos. No change was observed in the expression
pattern of other dorsally expressed mesodermal markers,
such as goosecoid, Otx-2, Xnot, noggin, and PAPC at the
early gastrula stage (data not shown). Thus, we conclude
that transient exposure of stage 10 gastrula to lithium does
not affect the expression and localization of dorsoventral
mesodermal genes at stage 10.5, at which time in situ
hybridization had revealed ectopic expression of XMyf5 and
XMyoD in the dorsal and ventral mesoderm. These analy-
ses, along with those showing that CSKA-Xwnt-8 and
lithium treatment were able to induce XMyf5 and XMyoD
expression in the ventral region of early gastrula, suggest
that zygotic Wnt signaling may induce the expression of
these genes independent of ventralization of the fate of
dorsal mesoderm.
Inhibition of Wnt/-Catenin Signaling Blocks
the Early Expression of XMyf5 and XMyoD
and Affects Muscle Development
To further examine which intracellular Wnt pathway is
required for XMyf5 and XMyoD expression, we overex-
pressed wild-type GSK-3 into the lateral region of four-
cell-stage embryos and then examined the expression pat-
tern of XMyf5 and XMyoD at stage 10.5. We also used a
dominant negative dishevelled mutant (Xdd1) and a domi-
nant negative Tcf3 mutant (dnTcf3). Lateral injection of 500
pg wild-type GSK-3, 2 ng Xdd1 or dnTcf3 mRNA blocked
the expression of both XMyf5 and XMyoD in the marginal
zone (Figs. 2A–2H). Thus, expression of both genes in the
two lateral mesodermal domains was either absent or
strongly reduced (Figs. 2B–2D and 2F–2H). This result was
further confirmed by RT-PCR analysis using GSK-3- or
Xdd1-injected early gastrula (Fig. 3B). However, the expres-
sion of the pan-mesodermal marker Xbra (Smith et al.,
1991) in the marginal zone was not affected in injected
embryos (Figs. 2I–2L). In addition, lateral injection of these
mRNAs did not affect the expression of Spemann organizer
markers (not shown). These analyses indicate that blocking
the Wnt/-catenin pathway may specifically affect XMyf5
and XMyoD expression. At tail-bud stages, injected em-
bryos exhibited trunk defects but with normal anterior
tissues, including eyes and cement gland. Typically, they
were kinked and had reduced somite numbers or disorga-
nized somites as revealed by the expression of the myosin
light chain gene (Figs. 2M–2P). However, injected embryos
did not exhibit complete absence of somitic mesoderm at
tail-bud stages; this may be due to the amounts and/or the
mosaic distribution of injected mRNA. It is also possible
that the most dorsal domain of XMyf5 expression has been
only partially affected.
Specific Induction of XMyf5 and XMyoD by Lithium
in Ectodermal Explants of Early Gastrula
The regulation of XMyf5 and XMyoD by zygotic Wnt/-
catenin signaling was then analyzed in vitro by using
animal cap explants dissected from stage 10 early gastrula,
treated with lithium, and cultured for 2 h. The result clearly
shows that lithium specifically induced the expression of
XMyf5. There was also a moderate increase in the expres-
sion level of XMyoD. However, the expression of other
dorsoventral markers, including Xwnt-8, Xbra, chordin,
and goosecoid, was not detected (Fig. 3A). The same result
was obtained through injection of CSKA-Xwnt-8 DNA (not
shown). Consistent with this result, injection of synthetic
dnTcf3 mRNA (2 ng) in animal caps reduced XMyf5 and
XMyoD expression induced by lithium (Fig. 3B). Since
dnTcf3 blocks lithium-induced XMyf5 expression in the
ectodermal explants independently of dorsoventral meso-
dermal patterning, these results suggest that zygotic Wnt/
-catenin pathway specifically induces XMyf5 expression
in naive ectodermal explants.
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Induction of XMyf5 Precedes That of XMyoD
In order to further examine how zygotic Wnt/-catenin
signaling regulates XMyf5 and XMyoD expression in the
presumptive mesoderm, we performed a time course anal-
ysis of the ectopic expression of these genes in the dorsal
mesoderm, following a transient exposure (15 min) of stage
10 gastrula to 0.3 M lithium. Whole-mount in situ hybrid-
ization was performed with control and treated embryos
cultured for a period ranging from 45 to 120 min. We
noticed that some stage 10 normal gastrula exhibited dorsal
expression of both XMyf5 and XMyoD in the Spemann
organizer field (see Table 1). The dorsal expression of both
genes disappears as gastrulation proceeds. Results from
three independent experiments are summarized in Table 1.
Compared with control embryos, a significant increase of
ectopic XMyf5 expression could be observed in embryos
cultured for 45 min following lithium treatment. At this
time point, a slight increase of ectopic XMyoD expression
could be observed. When cultured for 90 min, all lithium-
treated embryos exhibited ectopic XMyf5 expression,
whereas only 30% of lithium-treated embryos exhibited
ectopic XMyoD expression in the dorsal marginal zone.
After 120 min of culture, ectopic XMyoD expression was
observed in 70% of lithium-treated embryos. Thus, in
response to activation of Wnt/-catenin signaling, expres-
sion of XMyf5 precedes that of XMyoD, and may be consid-
ered as an immediate response.
To directly address this question, we analyzed by RT-
PCR the induction of XMyf5 and XMyoD in lithium-treated
ectoderm explants from different stages. Animal caps dis-
sected at stages 9, 10, and 11 were immediately treated with
lithium and cultured for 45 min. The result reproducibly
showed that lithium treatment strongly induced XMyf5
expression in animal cap explants dissected from different
stages. However, XMyoD expression was only moderately
induced by lithium when animal cap explants were dis-
sected at stage 11 (Fig. 3C). Alternatively, the same result
was obtained when animal cap explants were treated with
lithium at stage 9 and cultured to different stages; an
increase in XMyoD expression could be observed only after
a prolonged culture period (data not shown). This result
further indicates that the induction of XMyf5 expression by
zygotic Wnt/-catenin signaling precedes that of XMyoD.
FIG. 3. Regulation of XMyf5 and XMyoD expression by Wnt/-
catenin signaling pathway. (A) Animal cap explants were dissected
at stage 10.5, treated with lithium, and cultured for 2 h for RT-PCR
analysis of gene expression. Notice that lithium specifically in-
duces XMyf5 expression. A moderate induction XMyoD expression
can be detected. The expression of other dorsoventral mesodermal
genes is not induced. (B) Inhibition of XMyf5 and XMyoD expres-
sion by dnTcf3 in lithium-treated animal cap explants and by
GSK-3 and Xdd1 in early gastrula previously injected at four-cell
stage into the lateral marginal zone. (C) Lithium-induced expres-
sion of XMyf5 precedes that of XMyoD. RT-PCR analysis was
performed by using animal cap explants dissected from embryos at
indicated stages and cultured for 45 min following lithium treat-
ment. Strong XMyf5 expression induced by lithium treatment can
be observed independently of the developmental stages. Lithium
treatment does not induce XMyoD expression when assayed at
stages 9 and 10. A moderate induction can be observed at stage 11.
ODC was used as a loading control. RT, whole embryo control
sample without reverse transcriptase.
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Induction of XMyf5 by Lithium Is Not Blocked
by Protein Synthesis Inhibitor
The rapid response of XMyf5 expression after lithium
treatment implies that Wnt/-catenin signaling may di-
rectly activate its transcription. We thus analyzed the effect
of blocking protein synthesis in both whole embryo and
animal cap explants on the induction of XMyf5 expression
following lithium treatment. In a first set of experiments,
embryos at stage 10 were treated for 30 min with CHX to
inhibit protein synthesis. They were then treated with
lithium and cultured to stage 11 in the presence of CHX. In
situ hybridization was performed to analyze the expression
pattern of XMyf5 and XMyoD. CHX treatment alone did not
affect the expression and localization of XMyf5 in the two
lateral mesodermal domains (Figs. 4A and 4B), nor did it
affect lithium-induced ectopic expression of XMyf5 in both
dorsal and ventral mesoderm (Figs. 4C and 4D). However,
CHX affects the localization of XMyoD in the lateral
mesodermal domains (Figs. 4E and 4F); as a consequence, its
effect on ectopic XMyoD expression induced by lithium
could not be assayed (Figs. 4G and 4H). Nevertheless, this
observation suggests that protein synthesis is required for
the correct localization of XMyoD in the lateral mesoderm
domain. By contrast, the induction of XMyf5 expression by
Wnt/-catenin signaling can occur in the absence of protein
synthesis, arguing for a direct regulation.
The effect of CHX on lithium-induced XMyf5 expression
was then directly analyzed in animal cap explants dissected
TABLE 1
Time Course Induction of Ectopic XMyf5 and XMyoD Expression in the Dorsal Marginal Zone after Lithium Treatmenta
45 minb 90 minb 120 minb
Control Lithium Control Lithium Control Lithium
XMyf5 20 (30) 36 (30) 3 (30) 100 (30) 0 (30) 100 (27)
XMyoD 15 (30) 20 (30) 10 (30) 30 (30) 0 (30) 70 (30)
a Ectopic XMyf5 and XMyoD expression in the dorsal marginal zone was analyzed by whole-mount in situ hybridization. The results,
expressed as percentages, were obtained from 3 independent experiments with initially 10 embryos in each experiment. Numbers in
parentheses refer to total embryos analyzed.
b Time after lithium treatment.
FIG. 4. Ectopic expression of XMyf5 induced by lithium in the absence of protein synthesis. (A–H) Stage 10 gastrulae were first incubated
for 30 min in CHX solution and then treated with lithium. They were cultured to stage 11 in the presence of CHX. (A) XMyf5 expression
in a control untreated embryo. (B) XMyf5 expression pattern in an embryo treated with CHX alone is identical as in control embryo. (C)
A lithium-treated embryo showing ectopic XMyf5 expression in both dorsal and ventral mesoderm. (D) Double treatment with CHX and
lithium does not affect ectopic XMyf5 expression in dorsal and ventral mesoderm. (E) XMyoD expression in a control untreated embryo.
(F) CHX treatment abolishes localized XMyoD expression in the two lateral mesoderm domains. (G) A lithium-treated embryo showing
ectopic XMyoD expression in dorsal mesoderm. (H) Double treatment with CHX and lithium does not rescue normal XMyoD expression
pattern. (I) RT-PCR analysis of animal cap explants previously treated with CHX, lithium, or with CHX and lithium. CHX treatment alone
induces the expression of XMyf5, Xbra, and Xwnt-8. Lithium treatment only induces XMyf5 expression. Notice that CHX and lithium
additively induce XMyf5 expression.
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from stage 10.5 gastrula. They were first incubated for 30
min in the CHX solution and then treated with lithium for
15 min in the presence or absence of CHX. RT-PCR was
performed after 30 min of culture. XMyf5 expression was
detected in animal cap explants treated with CHX or
lithium alone. Importantly, they additively induced XMyf5
expression (Fig. 4I), consistent with in vivo analysis, indi-
cating that CHX did not block the effect of lithium. CHX
alone also induced the expression of the pan-mesodermal
marker Xbra and the lateroventral mesodermal marker
Xwnt-8. However, there was no additive effect between
CHX and lithium on their expression in animal cap ex-
plants (Fig. 4I). Since CHX blocks protein synthesis, the
increase in Xwnt-8 mRNA should not significantly affect
XMyf5 expression. Thus, this observation implies that
Wnt/-catenin signaling may directly activate XMyf5 tran-
scription at the early gastrula stage.
Interaction between FGF Signaling and Zygotic
Wnt/-Catenin Pathway in XMyf5 Expression
Although injection of CSKA-Xwnt-8 DNA or lithium
treatment could activate XMyf5 expression, they were not
able to induce muscle differentiation in ectodermal ex-
plants (Christian and Moon, 1993; data not shown). Mem-
bers of the FGF and TGF- families are potential inducers of
myogenic gene expression and muscle differentiation. Myo-
genesis also requires a community effect which may be
mediated by eFGF (Standley et al., 2001). To examine how
they interact with Wnt/-catenin signaling, four-cell-stage
embryos were injected with CSKA-Xwnt-8 DNA (50 pg) in
the four blastomeres near the animal pole region, and
animal caps were dissected at stage 8–9 and treated with
bFGF or activin. RT-PCR analysis indicates that injection
of 50 pg CSKA-Xwnt-8 DNA does not significantly induce
XMyf5 expression in ectodermal explants; however, it in-
teracts with bFGF, but not activin, to induce XMyf5 expres-
sion. By contrast, injection of Xwnt-8 mRNA (1 pg) reduced
XMyf5 expression induced by bFGF (Fig. 5), consistent with
the dorsalizing activity of maternal Wnt/-catenin signal-
ing. In addition, inhibition of Wnt/-catenin signaling only
blocked bFGF-induced XMyf5 expression, but had no effect
on activin. The same result was obtained by using eFGF.
Injection of 10 pg eFGF mRNA induced XMyf5 expression,
and coinjection with GSK-3 or dnTcf3 mRNA inhibited its
expression (Fig. 5), indicating an interaction between Wnt/
-catenin signaling and eFGF. Together with the result
which shows that blocking Wnt/-catenin signaling pro-
duces embryos with reduced somitic mesoderm (see Fig. 2),
these observations suggest that zygotic Wnt/-catenin
pathway may interact with FGF signaling to promote myo-
genic gene expression and myogenesis.
DISCUSSION
In this report, we have demonstrated that zygotic Wnt/
-catenin signaling differentially regulates the expression of
XMyf5 and XMyoD both in vivo and in vitro. We have used
transient exposure of whole embryos or explants to lithium
as a convenient tool to regulate the developmental stage at
which the pathway is activated. Our results reveal a specific
regulation of XMyf5 by zygotic Wnt/-catenin signaling and
a requirement for an intracellular signaling pathway that
involves inhibition of GSK-3 activity. Furthermore, we
provide the demonstration that Wnt/-catenin signaling
induces XMyf5 expression in the absence of protein synthe-
sis, arguing for a direct regulation.
Zygotic Wnt/-Catenin Signaling Specifically
Induces Ectopic XMyf5 Expression
at the Early Gastrula Stage
It was previously observed that misexpression of Xwnt-8
after MBT in the dorsal mesoderm produces anterior defi-
ciency, which may result from a ventralization of the fate of
dorsal mesoderm (Christian and Moon, 1993). In such
embryos at gastrula stages, ectopic XMyoD and XMyf5
expression could be observed in the dorsal region (Hoppler
and Moon, 1998; Marom et al., 1999). Other studies sug-
gested that the loss of anterior structures might result from
a distinct mechanism that involves the production of a
posteriorizing morphogen either by the dorsal mesoderm or
ectoderm (Fredieu et al., 1997). It is therefore not clear
whether Wnt/-catenin signaling regulates myogenic gene
expression. Our results clearly suggest that zygotic Wnt/-
catenin signaling is specifically implicated in regulating
XMyf5 expression at the early gastrula stage. In particular,
this regulation may be independent of ventralization of
dorsal mesoderm. Supporting this conclusion, we show first
that ventral injection of CSKA-Xwnt-8 was able to strongly
induce the ectopic expression of XMyf5 in both ventral
mesoderm and ventral ectoderm. Secondly, in situ hybrid-
ization analysis indicates that expression and localization
of Spemann organizer markers are not affected in lithium-
exposed early gastrula. This is consistent with the fact that
dorsal mesoderm is at least partially specified before expo-
sure of embryos to lithium. It was previously reported that
dorsal injection of CSKA-Xwnt-8 represses Xnot expression
in the Spemann organizer (Hoppler and Moon, 1998). We
did not observe a significant change in Xnot expression
pattern when stage 10 gastrulae were treated with lithium
and cultured to stage 10.5. However, Xnot expression was
indeed repressed in the dorsal mesoderm at a later stage
(data not shown). Thus, it is clear that the ectopic induction
of XMyf5 by lithium treatment precedes the repression of
Xnot in the dorsal mesoderm. The explanation for this
difference may be due to the fact that injection of CSKA-
Xwnt-8 results in relatively early expression of Xwnt-8 just
after MBT, while in our experiments, the exposure of
embryos to lithium was done at a significant later stage
(early gastrula). Consistent with this, when embryos were
treated with lithium at late blastula stage, a significant
reduced expression of Xnot could be observed at early
gastrula stage (Hamilton et al., 2001). It is also of note that
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lithium treatment does not modify the expression and
localization of the lateroventral mesodermal marker
Xwnt-8. In this regard, the effect of zygotic Wnt/-catenin
signaling is distinct from that of BMP-4, which has been
shown to ventralize dorsal mesoderm by repressing the
expression of chordin and by inducing Xvent-2 expression
in the dorsal mesoderm (Dosch et al., 1997). Therefore,
zygotic Wnt/-catenin signaling specifically regulates
XMyf5 expression, and to a lesser extent, the expression of
XMyoD. Our in vitro analysis is also consistent with this
result. We find that zygotic Wnt/-catenin signaling is able
to specifically induce the expression of XMyf5, but not that
of other dorsoventral mesodermal markers, including
goosecoid, chordin, Xbra, and Xwnt-8, in isolated ectoder-
mal explants soon after MBT (see Figs. 3 and 4I). These in
vivo and in vitro analyses argue for a specific regulation of
myogenic gene expression by zygotic Wnt/-catenin signal-
ing.
An Intracellular Wnt/-Catenin Pathway Is
Required for Myogenic Gene Expression
Functional analysis in Xenopus embryos has led to the
proposal that Wnts stimulate two distinct signaling path-
ways (reviewed by Miller et al., 1999; Pandur and Ku¨hl,
2001). The canonical Wnt/-catenin signaling pathway in-
volves dishevelled, the complex GSK-3/Axin/APC, and
-catenin, while the other pathway leads to an intracellular
calcium release in a G-protein-dependent fashion. Previous
studies using extracellular Wnt antagonists suggested an
implication of Wnt signaling in regulating XMyoD expres-
sion (Hoppler et al., 1996; Leyns et al., 1997; Wang et al.,
1997). We extended this observation using dominant nega-
tive mutants of the canonical Wnt/-catenin pathway,
which block signal transduction downstream of Wnt li-
gands. Thus, a dominant negative dishevelled mutant
(Xdd1), which blocks the canonical pathway (Sokol, 1996),
inhibits the expression of both XMyf5 and XMyoD in whole
embryos. In addition, ectopic expression of XMyf5 and
XMyoD induced by lithium treatment implies that the
regulation of these genes by extracellular Wnt signals
involves the intracellular inhibition of GSK-3 activity.
Consistent with this, overexpression of the wild-type
GSK-3 inhibits XMyf5 and XMyoD expression in the
lateral mesodermal domains. Importantly, we show that
overexpression of either Xdd1 or GSK-3 does not block
general mesoderm induction; the expression of the pan-
mesodermal marker Xbra (Smith et al., 1991) was not
affected in the entire marginal zone. We further show that
dnTcf3 blocks XMyf5 induction by lithium and CSKA-
Xwnt-8 injection in ectodermal explants. In this case, the
effect of dnTcf3 is independent of dorsoventral mesodermal
specification and patterning. Thus, our result suggests that
zygotic Wnt/-catenin pathway is involved in regulating
myogenic gene expression during gastrulation. The same
pathway at very early stages specifies dorsal axis by activat-
ing the expression of target gene like siamois (Carnac et al.,
1996; Brannon et al., 1997). The difference in target gene
expression during development may be a result of change in
the responsiveness of target promoter. Recently, it has been
shown that a hormone-inducible activated version of Tcf3
can reproduce both the early and late effects of Wnt/-
catenin signaling. In particular, when induced at the early
gastrula stage, it produces embryos with anterior deficien-
cies similar to CSKA-Xwnt-8 DNA injection (Darken and
Wilson, 2001). Thus, our result is consistent with this
observation.
Although inhibition of Wnt/-catenin signaling blocks
myogenesis and activation of this pathway is sufficient for
activating XMyf5 and XMyoD, CSKA-Xwnt-8-injected or
lithium-treated ectodermal explants did not form any rec-
ognizable muscle cells (Christian and Moon, 1993; data not
shown). This suggests that Wnt/-catenin signaling may
cooperate with another pathway to promote myogenesis.
Consistent with this suggestion, we have shown that the
zygotic, but not maternal, Wnt/-catenin pathway specifi-
cally interacts with FGF signaling to promote XMyf5 ex-
pression. Recently, eFGF has been shown to mediate a
community effect for myogenesis (Standley et al., 2001).
Thus, Wnt/-catenin signaling may cooperate with eFGF in
the embryo by inducing myogenic gene expression
A Direct Regulation of XMyf5 Expression
by Zygotic Wnt/-Catenin Signaling?
The Myf5 gene is under long-range regulation and regu-
latory regions with distinct properties are distributed over
96 kb upstream of the mouse Myf5 gene (Hadchouel et al.,
2000). We therefore chose transient exposure of embryos or
explants to lithium as a convenient tool to analyze the
mechanism of zygotic Wnt/-catenin signaling in regulat-
ing myogenic gene expression. Interesting information is
obtained by using this approach. First, we find that the
induction of XMyf5 expression precedes that of XMyoD.
Second, the expression of XMyf5 following lithium treat-
ment occurs within 30 min, arguing strongly for an
immediate-early response. Third, the induction takes place
in the absence of protein synthesis. Since lithium specifi-
cally induces XMyf5 expression in vivo and in vitro, these
results suggest that XMyf5 may be under direct regulation
by zygotic Wnt/-catenin signaling.
In contrast to the XMyoD gene (Harvey, 1991; Frank and
Harland, 1991; Rupp and Weintraub, 1991), XMyf5 gene is
not transiently expressed in the whole embryo at the time
of MBT (Hopwood et al., 1991). Based on the evidence
presented above and the expression pattern of Xwnt-8 in the
early gastrula, it is likely that XMyf5 represents a direct
target of zygotic Wnt/-catenin signaling. In the early
gastrula, expression of Xwnt-8 partially overlaps that of
XMyf5 (Dosch et al., 1997; this study). In addition, Xwnt-8
is a secreted protein that can act cell nonautonomously,
thus it is expressed at the right time and place to directly
regulate XMyf5 expression. Xwnt-8 is also expressed in the
ventral mesoderm, but its activity is likely inhibited by the
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secreted Wnt antagonist sizzled (Salic et al., 1997). The
regulation of XMyoD by zygotic Wnt/-catenin signaling is
not clear; however, it is unlikely that this signaling is
responsible for its transient expression in the whole embryo
since the induction of XMyoD following lithium treatment
is a delayed response. Two possibilities could account for
this delayed response. First, Wnt/-catenin signaling may
directly induce XMyoD expression only at the stage when
transiently expressed XMyoD mRNA declines to a signifi-
cantly low level. Second, the induction of XMyoD may be
mediated by XMyf5 protein, whereas Wnt/-catenin signal-
ing does not directly induce its expression. There are
several lines of evidences supporting the second possibility.
Wnt-1 activates the canonical Wnt/-catenin signaling
pathway (reviewed by Wodarz and Nusse, 1998), whereas
Wnt-7a activates a -catenin-independent pathway (Ken-
gaku et al., 1998). In isolated mouse paraxial mesodermal
explants, Myf5 expression is induced by Wnt-1, while
MyoD expression is induced by Wnt-7a (Tajbakhsh et al.,
1998). This raises the possibility that, in our experiments,
misexpression of Xwnt-8 or lithium treatment were not
directly inducing XMyoD expression, but through an indi-
rect mechanism. In both Xenopus and mouse embryos,
there are consistent results showing that XMyf5 acts up-
stream of XMyoD (Hopwood et al., 1991; Tajbakhsh et al.,
1997). While overexpression of XMyf5 in ectodermal ex-
plants strongly induces XMyoD expression, the converse
does not occur (Hopwood et al., 1991). In addition, CHX
treatment of early gastrula revealed that protein synthesis
is required for the expression of XMyoD in the two lateral
mesodermal domains, whereas it is not required for XMyf5
expression. The present study thus supports the proposal
that distinct Wnt signaling pathways underlie the activa-
tion of myogenesis in vertebrate embryo (Cossu and
Borello, 1999).
The late expression pattern of XMyf5 also fits with the
proposal that Wnt/-catenin signaling is involved in regu-
lating its expression. At tail-bud stages, XMyf5 is predomi-
nantly expressed in the dorsal tips of the somites with most
strong expression in the anterior region (see Fig. 2 in Dosch
et al., 1997). There are several lines of evidence that suggest
that the induction and patterning of dorsal somites are
mediated by the dorsal neural tube that expresses Wnt-1 or
by -catenin (Mu¨nsterberg et al., 1995; Stern et al., 1995;
Marcelle et al., 1997; Capdevila et al., 1998). This raises the
possibility that XMyf5 may be a target of Wnt/-catenin
signaling in different steps of myogenesis.
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